Sayed, D. and M. Abdellatif, 2010. AKT-ing via microRNA. Cell Cycle, 9: 3213-3237.CrossRef | PubMed |
Sayed, D., S. Rane and M. Abdellatif, 2009. MicroRNAs challenge the status quo of therapeutic targeting. J. Cardiovasc. Transl. Res., 2: 100-107.PubMed |
Chen, I.Y., J. Lupowy, J. Pain, D. Sayed and S. Grinberg et al
., 2006. Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J. Biol. Chem., 281: 19369-19377.PubMed |
Minghue, H., Z. Yang, D. Sayed, H. Minzhen, G. Shumin, L. Lin, S.H. Yoon andM. Abdellatif, 2012. GATA4 expression is primarily regulated via a mir-26-dependent posttranscriptional mechanism during cardiac hypertrophy. Cardiovasc Res., 4 .PubMed |
Rane, S., D. Sayed and M. Abdellatif, 2007. MicroRNA with a MacroFunction. Cell Cycle, 6: 1850-1855.
Rani, S., H. Minzhen, D. Sayed, Y. Lin, V. Dorothy and M. Abdellatif, 2010. An antagonism between the AKT and β -adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p. Cell. Signall., 22: 1054-1062.
Rani, S., H. Minzhen, D. Sayed, H. Vashistha and A. Malhotra et al
., 2009. Downregulation of MiR-199a derepresses hypoxia-inducible factor-1α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Cir. Res., 104: 879-886.CrossRef |
Sayed, D. and M. Abdellatif, 2011. MicroRNAs in development and disease. Physiol. Rev., 91: 827-887.CrossRef |
Sayed, D., H. Chull, I.Y. Chen, J. Lypowy and M. Abdellatif, 2007. MicroRNA play an essential role in the development of cardiac hypertrophy. Cir. Res., 100: 416-424.CrossRef |
Sayed, D., H. Minzhen, Z. Yang, S. Rani and M. Abdellatif, 2010. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas Ligand J. Bio. Chem., 285: 20281-20290.CrossRef | PubMed | Direct Link |
Sayed, D., S. Rane, J. Lypowy, M. He and I.Y. Chen et al
., 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol. Biol. Cell, 19: 3272-3282.PubMed |